Glingener Christoph 4
4 · ADTRAN Holdings, Inc. · Filed May 11, 2026
Research Summary
AI-generated summary of this filing
ADTRAN (ADTN) CTO Christoph Glingener Exercises Options, Sells Shares
What Happened
- Christoph Glingener, Chief Technology Officer of ADTRAN (ADTN), exercised stock options and sold the resulting shares. Between May 7–8, 2026 he exercised a total of 148,392 shares (exercises at $7.01 and $12.17) and sold the same 148,392 shares in open-market transactions for aggregate proceeds of about $2.22 million. The reported exercise costs were about $1.59 million. The transactions were made under a pre-established Rule 10b5-1 trading plan.
Key Details
- Transaction dates: May 7–8, 2026.
- Exercises (acquisitions): 41,220 shares @ $7.01 (cost $288,952); 84,895 shares @ $12.17 (cost $1,033,172); 22,277 shares @ $12.17 (cost $271,111).
- Sales (dispositions): 41,220 shares @ weighted avg $14.73 (proceeds $607,171; prices ranged $14.355–$15.69 per footnote); 84,895 shares @ weighted avg $15.06 (proceeds $1,278,519; prices ranged $15.00–$15.69 per footnote); 22,277 shares @ $15.00 (proceeds $334,155).
- Total shares exercised/sold: 148,392; total proceeds ≈ $2.22M; total exercise cost ≈ $1.59M.
- Shares owned after transaction: not specified in the filing.
- Footnotes of note: F1 — transactions executed under a Rule 10b5-1 plan adopted Dec 12, 2025; F2–F4 — sale prices reported as weighted averages with price ranges; F5 — an option was vested and fully exercisable; F6 — another option vests May 15, 2026.
- Filing: Form 4 filed May 11, 2026 (no late filing indicated in the report).
Context
- These transactions are typical option exercises followed by immediate open-market sales (shares exercised and then sold the same day or the next day). Such patterns often reflect exercising to cover option costs/taxes or to monetize vested equity; they do not, by themselves, indicate management’s view of the company’s prospects. The 10b5-1 plan note means the sales were made under a pre-set trading plan.
Insider Transaction Report
Form 4
Glingener Christoph
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-05-07$7.01/sh+41,220$288,952→ 87,865 total - Sale
Common Stock
[F1][F2]2026-05-07$14.73/sh−41,220$607,171→ 46,645 total - Exercise/Conversion
Common Stock
[F1]2026-05-07$12.17/sh+84,895$1,033,172→ 131,540 total - Sale
Common Stock
[F1][F3]2026-05-07$15.06/sh−84,895$1,278,519→ 46,645 total - Exercise/Conversion
Common Stock
[F1]2026-05-08$12.17/sh+22,277$271,111→ 68,922 total - Sale
Common Stock
[F1][F4]2026-05-08$15.00/sh−22,277$334,155→ 46,645 total - Exercise/Conversion
Stock Option
[F1][F5]2026-05-07−41,220→ 0 totalExercise: $7.01Exp: 2027-05-14→ Common Stock (41,220 underlying) - Exercise/Conversion
Stock Options
[F1][F5]2026-05-07−84,895→ 22,277 totalExercise: $12.17Exp: 2028-05-14→ Common Stock (84,895 underlying) - Exercise/Conversion
Stock Option
[F1][F5]2026-05-08−22,277→ 0 totalExercise: $12.17Exp: 2028-05-14→ Common Stock (22,277 underlying)
Holdings
- 85,383
Stock Option
[F6]Exercise: $19.08Exp: 2029-05-14→ Common Stock (85,383 underlying)
Footnotes (6)
- [F1]The transactions reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.355 to $15.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- [F4]These shares were sold in a single transaction at $15.00 per share.
- [F5]The stock option vested and was fully exercisable.
- [F6]The stock option vests on May 15, 2026, which is the fourth anniversary of the date of the grant.
Signature
/s/ Dan Ragsdale, by power of attorney|2026-05-11